HIGHFDA DRUG

Gold Star Distribution Recalls Excedrin Migraine 2's 25 CT Over Rodent-Contamination Risk (2026)

Gold Star Distribution recalls Excedrin Migraine 2's, 25-count bottles distributed nationwide in the United States. CGMP deviations involve insanitary conditions including rodent exposure in the distribution center. Consumers and healthcare providers should stop using the product immediately and contact Gold Star Distribution or their healthcare provider for guidance.

Official notice
Gold Star DistributionHealth & Personal CareDrugs & MedicationsAll lots within expiry distributed by Gold Star Distribution.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
December 26, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 26, 2025
Hazard Level
HIGH
Brand
Gold Star Distribution
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Gold Star Distribution
Product type
Analgesic (OTC Pain Reliever)
Model numbers
All lots within expiry distributed by Gold Star Distribution.
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 26, 2025

  2. Reported by FDA DRUG

    January 21, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact GOLD STAR DISTRIBUTION INC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

About This Product

Excedrin Migraine is an over-the-counter analgesic used to treat migraine symptoms. It is distributed nationwide in the United States by Gold Star Distribution.

Why This Is Dangerous

The hazard stems from insanitary conditions and potential rodent exposure in the distribution center, which could contaminate products before reaching consumers.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers may need to discard affected product and seek alternative treatments. The recall creates inconvenience and potential health concerns for those relying on this medication.

Practical Guidance

How to identify if yours is affected

  1. Check your Excedrin Migraine 2's 25-count packaging for distribution by Gold Star Distribution.
  2. Verify the lot is within expiry and that it was distributed by Gold Star Distribution.
  3. If in doubt, consult the recall notice page for confirmation.

Where to find product info

FDA enforcement report D-0270-2026 and the linked recall page.

What timeline to expect

Unknown. The notice does not specify a refund or replacement timeline.

If the manufacturer is unresponsive

  • Escalate to FDA recall office if the distributor is non-responsive.
  • Document communications and retain packaging, photos, and recall notices.

How to prevent similar issues

  • Buy from reputable retailers and verify CGMP compliance.
  • Inspect packaging for tampering or damage before use.
  • Store medications securely to prevent mix-ups during recalls.

Documentation advice

Keep the product, packaging, recall notice, and all correspondence with the distributor as part of your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Excedrin Migraine 2's - 25 CT Distributor: Gold Star Distribution Distribution: US Nationwide Recall Date: 2025-12-26 Status: Active Recall Number: D-0270-2026 Model numbers: All lots within expiry distributed by Gold Star Distribution Price: Unknown

Key Facts

  • 1 recall involving Excedrin Migraine 2's 25-count distributed nationwide by Gold Star Distribution
  • Recall Number D-0270-2026
  • Hazard: CGMP deviations due to insanitary conditions including rodent exposure
  • All lots within expiry distributed by Gold Star Distribution are affected
  • No injuries or illnesses reported in the recall notice

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
All lots within expiry distributed by Gold Star Distribution.
Affected States
ALL
Report Date
January 21, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls